Tinostamustine Recruiting Phase 1 Trials for Malignant Melanoma Treatment

IndicationsStatusPurposePhase
RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT03903458Tinostamustine and Nivolumab in Advanced Melanoma